2020
DOI: 10.1016/j.aller.2019.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 18 publications
2
9
0
Order By: Relevance
“…According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standard, 47 the standard literature selection process was conducted as shown in Figure 1 . We finally included 72 articles 21 , 22 , 25 31 , 48 …”
Section: Resultsmentioning
confidence: 99%
“…According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standard, 47 the standard literature selection process was conducted as shown in Figure 1 . We finally included 72 articles 21 , 22 , 25 31 , 48 …”
Section: Resultsmentioning
confidence: 99%
“…ANXA1 is an anti-inflammatory mediator that reduces neutrophil migration [ 31 ] and could be acting to regulate the inflammation generated by the high number of neutrophils in neutrophilic asthma. Many studies have demonstrated its important role in asthma, and even suggested ANXA1 as a therapeutic target for this pathology [ 32 , 33 , 34 ]. Nevertheless, just recently, it was shown to be a predictive protein for neutrophilic asthma, although it was not different between the other asthma phenotypes [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…As far as we know, there is no study that prove that the Anxa1 gene may relate to the pathogenesis of AR. However, some relevant studies in asthma suggest that Anxa1 may play a role in AR (Cui and Yang, 2018;Lee et al, 2018;Ibrahim et al, 2020).…”
Section: Discussionmentioning
confidence: 99%